Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Suzuki, Ritsuro  [Clear All Filters]
2019
Kondo, E., Shimizu-Koresawa, R., Chihara, D., Mizuta, S., Izutsu, K., Ikegame, K., Uchida, N., Fukuda, T., Ichinohe, T., Atsuta, Y., et al. (2019). Allogeneic haematopoietic stem cell transplantation for primary mediastinal large B-cell lymphoma patients relapsing after high dose chemotherapy with autologous stem cell transplantation: data from the Japan Society for Haematopoietic Cell Transplantatio.Br J Haematol.
Yamasaki, S., Nitta, H., Kondo, E., Uchida, N., Miyazaki, T., Ishiyama, K., Kiyota, M., Matsuoka, H., Ichinohe, T., Fukuda, T., et al. (2019). Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.Ann Hematol.
Kondo, E., Ikeda, T., Izutsu, K., Chihara, D., Shimizu-Koresawa, R., Fujii, N., Sakai, T., Kondo, T., Kubo, K., Kato, Y., et al. (2019). High dose chemotherapy with autologous stem cell transplantation in primary central nervous system lymphoma: Data from the Japan Society for Hematopoietic Cell Transplantation (JSHCT) registry.Biol Blood Marrow Transplant.
Kim, S.-W., Asakura, Y., Tajima, K., Iwai, T., Taji, H., Chou, T., Morishima, Y., Suzumiya, J., Sakamaki, H., Suzuki, R., et al. (2019). High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey.Int J Hematol.
Kawashima, N., Iida, M., Suzuki, R., Fukuda, T., Atsuta, Y., Hashii, Y., Inoue, M., Kobayashi, M., Yabe, H., Okada, K., et al. (2019). Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.Int J Hematol.
Fujimoto, A., Hiramoto, N., Yamasaki, S., Inamoto, Y., Uchida, N., Maeda, T., Mori, T., Kanda, Y., Kondo, T., Shiratori, S., et al. (2019). Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.